"The Cardiac & Vascular Institute (TCAVI) provides specialized cardiology and vascular care to North Central Florida with offices located in both Gainesville and Lake City, Florida. TCAVI is committed to providing the highest quality state-of-the-art health services to our patients. With 18 cardiologists, two electrophysiologists, and two vascular surgeons providing diagnostic, therapeutic and preventive cardiac services, TCAVI specializes in areas including atrial fibrillation, hypertension management, heart failure management, minimally invasive valve repair or replacement, peripheral vascular disease, and critical limb ischemia."

During the past decade, The Cardiac and Vascular Institute conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 12 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Cardiac and Vascular Institute" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials sponsored, "ReCor Medical, Inc." with 3 trials sponsored, "Spectranetics Corporation" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Cardiac and Vascular Institute" #1 collaborator was "Libra Medical" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bard Ltd" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "EKOS Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "The Cardiac and Vascular Institute" are "Peripheral Arterial Disease" (8 trials), "Coronary Artery Disease" (5 trials), "Peripheral Artery Disease" (4 trials), "Vascular Diseases" (4 trials) and "Critical Limb Ischemia" (3 trials). Many other conditions were trialed in "The Cardiac and Vascular Institute" in a lesser frequency.

Most popular intervention types in "The Cardiac and Vascular Institute" are "Device" (23 trials), "Drug" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "ABT NG DES 48 EECSS" (1 trials), "Acetylsalicylic Acid" (1 trials), "Arm 1: treatment with Neovasc Reducer" (1 trials), "Arm 2 (control): Implantation procedure with no device implanted" (1 trials) and "Arm 3 (unblinded, non-randomized): Single arm registry" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Cardiac and Vascular Institute" are 32 trials for "All" genders.

Currently, there are NaN active trials in "The Cardiac and Vascular Institute". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in The Cardiac and Vascular Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Cardiac and Vascular Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 19 trials that are defined as “Not Applicable".

The Cardiac and Vascular Institute has several departments that took part in Clinical trials: "The Cardiac and Vascular Institute Research Foundation" - 6 trials, "The Cardiac & Vascular Institute Research Foundation" - 4 trials